Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
The Journal of Rheumatology|February 17, 2015
The OMERACT MRI in Arthritis Working Group - Update on Status and Future Research PrioritiesMikkel Østergaard, Paul Bird, Frédérique Gandjbakhch, et al.
Annals of the Rheumatic Diseases|December 16, 2018
Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritisMargreet Kloppenburg, Charles Peterfy, Ida K Haugen, et al.
The Oncologist|July 4, 2025
Long-term efficacy and safety of pexidartinib in patients with tenosynovial giant cell tumor: final results of the ENLIVEN studyAndrew J Wagner, William D Tap, Sebastian Bauer, et al.
The Journal of Rheumatology|August 13, 2009
The OMERACT MRI inflammatory arthritis group: advances and future research prioritiesPhilip G Conaghan, Paul Bird, Fiona McQueen, et al.
Future Oncology (London, England)|January 18, 2022
CSF1 receptor inhibition of tenosynovial giant cell tumor using novel disease-specific MRI measures of tumor burdenCharles Peterfy, Yan Chen, Peter Countryman, et al.
The Journal of Rheumatology|December 3, 2013
Update on the OMERACT magnetic resonance imaging task force: research and future directionsPhilip G Conaghan, Fiona M McQueen, Paul Bird, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 18, 2019
A Phase II Trial of Lutikizumab, an Anti-Interleukin-1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With SynovitisRoy M Fleischmann, Henning Bliddal, Francisco J Blanco, et al.
The Journal of Rheumatology|February 17, 2019
Development and Validation of an OMERACT MRI Whole-Body Score for Inflammation in Peripheral Joints and Entheses in Inflammatory Arthritis (MRI-WIPE)Simon Krabbe, Iris Eshed, Frédérique Gandjbakhch, et al.
Lancet (London, England)|June 24, 2019
Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trialWilliam D Tap, Hans Gelderblom, Emanuela Palmerini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2021
Results from Phase I Extension Study Assessing Pexidartinib Treatment in Six Cohorts with Solid Tumors including TGCT, and Abnormal CSF1 Transcripts in TGCTWilliam D Tap, Arun S Singh, Stephen Patrick Anthony, et al.
Pageof 8